China’s single-shot Covid-19 vaccine safe for children at lower dosage, tests find

Published Sep 24 2021 at 6:00 AM GMT
  • CanSino Biologics’ single-dose Covid-19 vaccine, given at a lower dosage than that for adults, is safe and triggers an immune response in children aged six-17, results from a small trial showed.
  • Researchers decided to lower the dosage after a few participants developed fever and headaches graded at level 2 severity – the second-lowest of four levels.
  • In children, the lower dose triggered higher antibody levels than the dosage approved for use in adults in China, according to the peer-reviewed….



  • Published Sep 24, 2021 6:00 AM GMT